These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium. Vogelmeier C, Aquino TO, O'Brien CD, Perrett J, Gunawardena KA. COPD; 2012 Apr; 9(2):111-20. PubMed ID: 22458939 [Abstract] [Full Text] [Related]
3. Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis. Stockley R, De Soyza A, Gunawardena K, Perrett J, Forsman-Semb K, Entwistle N, Snell N. Respir Med; 2013 Apr; 107(4):524-33. PubMed ID: 23433769 [Abstract] [Full Text] [Related]
4. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. Partridge MR, Schuermann W, Beckman O, Persson T, Polanowski T. Ther Adv Respir Dis; 2009 Aug; 3(4):1-11. PubMed ID: 19734176 [Abstract] [Full Text] [Related]
6. Efficacy and safety of budesonide/formoterol via a dry powder inhaler in Chinese patients with chronic obstructive pulmonary disease. Zhong N, Zheng J, Wen F, Yang L, Chen P, Xiu Q, Yao W, Sun T, Zhao Z, Shen H, Shi Y, Lin J, Li Q. Curr Med Res Opin; 2012 Feb; 28(2):257-65. PubMed ID: 22046961 [Abstract] [Full Text] [Related]
7. Feasibility of Computed Tomography in a Multicenter COPD Trial: A Study of the Effect of AZD9668 on Structural Airway Changes. Nordenmark LH, Taylor R, Jorup C. Adv Ther; 2015 Jun; 32(6):548-66. PubMed ID: 26043724 [Abstract] [Full Text] [Related]
13. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial. Rennard SI, Tashkin DP, McElhattan J, Goldman M, Ramachandran S, Martin UJ, Silkoff PE. Drugs; 2009 Dec; 69(5):549-65. PubMed ID: 19368417 [Abstract] [Full Text] [Related]
14. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. Bathoorn E, Liesker JJ, Postma DS, Boorsma M, Bondesson E, Koëter GH, Kauffman HF, van Oosterhout AJ, Kerstjens HA. COPD; 2008 Oct; 5(5):282-90. PubMed ID: 18972276 [Abstract] [Full Text] [Related]
15. Beclomethasone/formoterol in the management of COPD: a randomised controlled trial. Calverley PM, Kuna P, Monsó E, Costantini M, Petruzzelli S, Sergio F, Varoli G, Papi A, Brusasco V. Respir Med; 2010 Dec; 104(12):1858-68. PubMed ID: 20965712 [Abstract] [Full Text] [Related]